ALKS


Also found in: Medical.
AcronymDefinition
ALKSAlkermes, Inc. (stock symbol)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in classic literature ?
"He is privileged to t alk as he pleases; and he is very tiresome and slovenly in his habits; but he means no harm."
- Dublin, Ireland-based global biopharmaceutical company Alkermes plc (NASDAQ: ALKS) has completed patient enrollment in ENLIGHTEN-2, the second of two key phase 3 studies in the ENLIGHTEN clinical development program for ALKS 3831, an investigational, novel, once-daily, oral atypical antipsychotic drug candidate for the treatment of schizophrenia, the company said.
Biopharmaceutical company Alkermes plc (Nasdaq:ALKS) said on Monday that it has filed for review the New Drug Application (NDA) for ALKS 5461 with the US Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD), a condition in which patients exhibit depressive symptoms.
ALKS 7106 represents a new class of analgesic agents known as potent opioid modulators, designed for the treatment of pain with low potential for abuse and overdose, liabilities associated with opioid analgesics.
ALKS 33 was designed to provide minimally metabolized, highly potent, and sublingually bioavailable mu antagonism to allow for effective coformulation of the two agents.
The multicenter, randomised, double-blind phase 3 study will evaluate the weight gain profile of ALKS 3831 compared to olanzapine, an established atypical antipsychotic agent with proven efficacy but also metabolic liabilities, in patients with stable schizophrenia over a six-month treatment period.
Biopharmaceutical company Alkermes plc (NASDAQ:ALKS) said on Wednesday that it has successfully filed its New Drug Application (NDA) for ALKS 5461 with the US Food and Drug Administration for the adjunctive treatment of major depressive disorder (MDD).
Indeed, ALKS 5461 may represent a new rapid-onset treatment approach for depression and other psychiatric disorders, such as addictive disorder, he said.
According to the terms of the contract, Biogen will receive an exclusive, worldwide license to commercialise ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of the product.
Biopharmaceutical company Alkermes (NasdaqGS:ALKS) reported on Monday the launch of a randomized, double-blind, parallel-group study designed to evaluate the exploratory metabolic profile of ALKS 3831 when compared to olanzapine for the treatment of schizophrenia under the ENLIGHTEN pivotal programme.
After the market close on February 1, Alkermes (ALKS) announced it received a Complete Response Letter, or CRL, from the FDA regarding its New Drug Application, or NDA, for ALKS 5461 for the adjunctive treatment of major depressive disorder, or MDD.
M2 EQUITYBITES-August 26, 2014-Alkermes begins Phase 1 clinical study of ALKS 7106 for treatment of pain, with intrinsically low potential for abuse and overdose death